A Phase II Trial of Cytarabine and Clofarabine in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Clofarabine (Primary) ; Cytarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 25 Mar 2015 Biomarkers information updated
- 09 Jul 2012 Planned end date changed from 1 Dec 2008 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 23 Jul 2008 Status changed from recruiting to in progress, from clinicaltrials.gov record.